Spatial transcriptomics is a groundbreaking technology that allows the measurement of the activity of thousands of genes in a tissue sample and maps where the activity occurs. This technology has enabled the study of the spatial variation of the genes across the tissue. Comprehending gene functions and interactions in different areas of the tissue is of great scientific interest, as it might lead to a deeper understanding of several key biological mechanisms, such as cell-cell communication or tumor-microenvironment interaction. To do so, one can group cells of the same type and genes that exhibit similar expression patterns. However, adequate statistical tools that exploit the previously unavailable spatial information to more coherently group cells and genes are still lacking. In this work we introduce SpaRTaCo, a new statistical model that clusters the spatial expression profiles of the genes according to a partition of the tissue. This is accomplished by performing a co-clustering, that is, inferring the latent block structure of the data and inducing two types of clustering: of the genes, using their expression across the tissue, and of the image areas, using the gene expression in the spots where the RNA is collected. Our proposed methodology is validated with a series of simulation experiments, and its usefulness in responding to specific biological questions is illustrated with an application to a human brain tissue sample processed with the 10X-Visium protocol.
5 October 2023 in Statistical Methods & Applications
Sky surveys represent the fundamental data basis for detecting and locating as yet undiscovered celestial objects. Since 2008, the Fermi LAT Collaboration has catalogued thousands of $$\gamma$$ -ray sources with the aim of extending our knowledge of the highly energetic physical mechanisms and processes that lie at the core of our Universe. In this article, we present a nonparametric clustering algorithm which identifies high-energy astronomical sources using the spatial information of the $$\gamma$$ -ray photons detected by the large area telescope onboard the Fermi spacecraft. In particular, the sources are identified using a von Mises–Fisher kernel estimate of the photon count density on the unit sphere via an adjustment of the mean-shift algorithm which accounts for the directional nature of the collected data and the need of local smoothing. This choice entails a number of desirable benefits. It allows us to bypass the difficulties inherent on the borders of any projection of the photon directions onto a 2-dimensional plane, while guaranteeing high flexibility. The smoothing parameter is chosen adaptively, by combining scientific input with optimal selection guidelines, as known from the literature. Using statistical tools from hypothesis testing and classification, we furthermore present an automatic way to skim off sound candidate sources from the $$\gamma$$ -ray emitting diffuse background and to quantify their significance. We calibrate and test our algorithm on simulated count maps provided by the Fermi LAT Collaboration.
Background: Multiple sclerosis (MS) is a chronic autoimmune disease of the central nervous system, with symptoms that greatly affect quality of life (QoL). One of the most prevalent symptoms of MS is fatigue, also one of the main factors reducing QoL. Low levels of vitamin D (VD) are associated with worse QoL and with increased risk of developing more severe forms of the disease. Methods: In this cross-sectional study, we compared perceptions of quality of life and fatigue in 324 patients, subdivided into four groups, according to their treatment: high-dose VD therapy only, disease-modifying therapy (DMT) only, both treatments, and no treatments. All subjects completed the MSQOL-54 and the FSS questionnaires via an online survey. Results: High-dose VD treatment was associated with an increased perception of physical QoL (83.60 vs. 66.92, p < 0.001), mental QoL (75.52 vs. 59.80, p < 0.001), and fatigue (1.89 vs. 2.98, p < 0.001), compared to the DMT-only group. Treatment with DMT was associated with a worse perception of physical QoL compared to no treatment (70.58 vs. 76.53, p = 0.024). Conclusions: high-dose VD treatment is well-tolerated and associated with an increased perception of QoL in people with MS.
12 December 2025 in Environmental and Ecological Statistics
Detecting geographical areas in a territory with excess mortality is a crucial step to understand health disparities and implement effective public health policies. In practice, this means identifying both individual areas and clusters of neighbouring areas where mortality is higher than in the rest of the territory. Mortality clusters are commonly detected using spatial scan statistics, which are tools that scan the territory with moving windows and test the presence of excess mortality. However, these techniques often detect spurious clusters or encompass areas not at risk into existing clusters, leading to unreliable epidemiological results. Here, we propose a data-driven initialisation of a generalised linear model scan statistic that improves its specificity and reduces its computational cost. Our strategy consists of identifying individual areas with a significant mortality excess through an improved version of the Besag–York–Mollié model, and using them to initialise the clustering procedure. We investigate the properties of our method with a series of simulation experiments, showing that our proposed initialisation increases clustering specificity relative to standard approaches and also prevents the erroneous inclusion of areas not at risk within clusters of elevated mortality. Finally, we demonstrate the usefulness of the proposed tool for healthcare authorities using a case study on mortality data from the Padua province in northeastern Italy.
Spatial transcriptomics measures the expression of thousands of genes in a tissue sample while preserving its spatial structure. This class of technologies has enabled the investigation of the spatial variation of gene expressions and their impact on specific biological processes. Identifying genes with similar expression profiles is of utmost importance, thus motivating the development of flexible methods leveraging spatial data structure to cluster genes. Here, we propose a modeling framework for clustering observations measured over numerous spatial locations via Gaussian processes. Rather than specifying their covariance kernels as a function of the spatial structure, we use it to inform a generalized Cholesky decomposition of their precision matrices. This approach prevents issues with kernel misspecification and facilitates the estimation of a non-stationarity spatial covariance structure. Applied to spatial transcriptomic data, our model identifies gene clusters with distinctive spatial correlation patterns across tissue areas comprising different cell types, like tumoral and stromal areas.
Summary: Disease mapping analyses the distribution of several disease outcomes within a territory. Primary goals include identifying areas with unexpected changes in mortality rates, studying the relation among multiple diseases, and dividing the analysed territory into clusters based on the observed levels of disease incidence or mortality. In this work, we focus on detecting spatial mortality clusters, that occur when neighbouring areas within a territory exhibit similar mortality levels due to one or more diseases. When multiple causes of death are examined together, it is relevant to identify not only the spatial boundaries of the clusters but also the diseases that lead to their formation. However, existing methods in literature struggle to address this dual problem effectively and simultaneously. To overcome these limitations, we introduce perla, a multivariate Bayesian model that clusters areas in a territory according to the observed mortality rates of multiple causes of death, also exploiting the information of external covariates. Our model incorporates the spatial structure of data directly into the clustering probabilities by leveraging the stick-breaking formulation of the multinomial distribution. Additionally, it exploits suitable global-local shrinkage priors to ensure that the detection of clusters depends on diseases showing concrete increases or decreases in mortality levels, while excluding uninformative diseases. We propose a Markov chain Monte Carlo algorithm for posterior inference that consists of closed-form Gibbs sampling moves for nearly every model parameter, without requiring complex tuning operations. This work is primarily motivated by a case study on the territory of a local unit within the Italian public healthcare system, known as ULSS6 Euganea. To demonstrate the flexibility and effectiveness of our methodology, we also validate perla with a series of simulation experiments and an extensive case study on mortality levels in U.S. counties.